Spots Global Cancer Trial Database for Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
Official Title: A Prospective, Open-labelled, Randomized, Multicenter Phase II Study to Evaluate Efficacy and Safety of Erlotinib vs NP Chemotherapy as Adjuvant Therapy in Post Radical Operation NSCLC Patients With EGFR19 or 21 Exon Mutation
Study ID: NCT01683175
Conditions
Study Description
Brief Summary: This study is to compare 2-year Disease Free Survival Rate (DFSR) in post radical operation IIIA Non-Small Cell Lung Cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) 19 or 21 exon mutation treated Erlotinib vs NP chemotherapy as adjuvant therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Beijing Cancer Hospital, Beijing, , China
Chinese PLA General Hospital, Beijing, , China
The second people's hospital of Sichuan, Chengdu, , China
Fujian Medical University Union Hospital, Fuzhou, , China
Sun Yat-Sen University Cancer Center, Guangzhou, , China
Zhejiang Cancer Hospital, Hangzhou, , China
The third affiliated hospital of Harbin Medical Univer, Harbin, , China
The affiliated hospital of medical college Qingdao University, Qingdao, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
Zhongshan Hospital Fudan University, Shanghai, , China
Liaoning Cancer Hospital & Institute, Shenyang, , China
Hebei Provincial Tumor Hospital, Shijiazhuang, , China
The first affiliated hospital of Soochow University, Suzhou, , China
The fourth military medical university，Tangdu Hospital, Xi'an, , China
Contact Details
Name: Changli Wang
Affiliation: Tianjin Medical University Cancer Institute and Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
